For speculators intrigued by discounts among blue-chip giants, healthcare juggernaut AbbVie (ABBV) is well worth consideration. Recently, ABBV stock triggered an unusual quantitative signal. In the ...
Smart money is showing caution: increasing hedges, raising international allocations (so they say), and reducing ETF exposure, despite maintaining high overall equity positions. Fund managers view US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results